Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Investor Relations

Employer
Nektar Therapeutics
Location
San Francisco, CA, United States
Start date
Oct 4, 2019

View more

Job Details

Position Overview

The Director, Investor Relations reports directly to the Sr. VP, Strategy & Corporate Affairs and will work closely and collaboratively cross-functionally across the company and with senior management at Nektar.

The Director, Investor Relations reports directly to the Sr. VP, Strategy & Corporate Affairs and will work closely and collaboratively cross-functionally across the company and with senior management at Nektar. The individual will be tasked with helping to develop and execute Nektar's Investor Relations strategy and increasing the company's visibility with the investment community, which includes dissemination of the Company's corporate message, interactions with the investment community and identifying and targeting key investor groups in the U.S., Europe and Asia. He/she is expected to take on a significant role in interfacing with the investment community while serving as a credible and timely source of information and primary point of contact to key investors and analysts.

Essential duties and responsibilities include but are not limited to the following:
  • Maintains comprehensive knowledge of Nektar's products, research pipeline and business strategies to assist in representing the Company to the investment community and Wall Street analysts.
  • Monitors and analyzes data relating to trading activity, relevant industry data, and peer company performance
  • Prepares materials tracking detailed stock trading and shareholder information for presentations to Senior Management
  • Tracks, reviews, and compiles detailed financial models on a quarterly basis and maintains a dynamic, detailed, internal consensus financial model, based on covering sell- side analyst models
  • Analyzes internal and external forecasts, data, and assumptions to provide aggregated view of expectations and implications for stock price and investor and analysts perception
  • Creates and updates investor presentations, messaging and Q&A documents
  • Leads financial results press release process, including preparation of draft release for BOD packages and coordination across departments to ensure accuracy of content as well as drafting of script for financial results call with investors
  • Provides reporting to senior leadership on analyst reports from covering analysts
  • Maintains database of investor and analyst meetings
  • Responsible for investor relations portion of corporate website
  • Respond to investors and analyst inquiries in a timely manner
  • May serve as spokesperson in meetings with investors and analysts
  • Ensures compliance with Regulation FD and liaises with legal department on all public communications materials
  • Liaises with Media Relations and Corporate Communications on materials such as press releases and earnings releases, for dissemination to the public.
  • Prioritizes and organizes external meeting requests with investors and analysts, determining necessary executive presence.
  • Manages and attends select investor conferences, events, and investor and analyst meetings
  • Develops relationships and maintains regular communication with individual investors and select buy-side and sell-side contacts to provide up to date information about events and market trends affecting the Company, with the goal of communicating our long-term vision.
  • Develops plan for targeted marketing activities to new and existing shareholders and potential sell-side research analysts
  • Stays abreast of competitive commercial and research products/programs.
  • Work collaboratively and cross functionally with internal stakeholders, including Legal, Regulatory, Medical Affairs and Patient Advocacy
Position Requirements and Experience: Education and Experience:
  • Minimum of a BA/BS degree in a scientific discipline or related Ph.D. desired
  • A minimum of 12 years experience in biotech or related industries. A minimum of 8 years direct investor relations experience within a public pharmaceutical or biotechnology company with an Oncology focus is required.
  • Direct work experience in the investment community on the buy or sell-side a plus
  • Established credibility with the investment community and biotechnology industry
Knowledge/Skills/Abilities:
  • Strong communications strengths and proven communications track record demonstrating written, verbal, presentation, interpersonal skills combined with ability to translate and simplify complex information for research analysts and investors.
  • Demonstrated ability to understand and communicate complex scientific concepts
  • Demonstrated ability to work collaboratively and cross-functionally across the organization to align messaging and develop external IR materials
  • Proven track record of meeting deadlines, including for public disclosures and Board of Director packages
  • Proven ability to manage budget and direct external consulting agencies
  • Team player who displays flexibility and professionalism under pressure
  • Understanding of financial statements and analyst valuation models
  • Understanding of SEC and FDA regulations impacting communications
  • Strong organizational and prioritization skills and attention to detail
  • Impeccable/Solid judgement
  • Excellent written, verbal and PowerPoint skills
  • Excellent research abilities, outstanding attention to detail, efficient time management abilities and the willingness and ability to maintain and foster relationships
  • Ability to travel up to 50%
We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class. Nektar Therapeutics will consider for employment qualified applicants with criminal histories in the manner proscribed by the San Francisco Fair Chance Ordinance.

Company

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer and auto-immune disease. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. Our success is rooted in four key elements: our track record reflected by a portfolio of successful approved medicines which emanated from our chemistry platform and are made available globally by our pharmaceutical partners, our unique research and development pipeline of new investigational medicines in cancer and immunology, our proprietary and proven science and technology approach that fuels our discovery efforts and our team of dedicated scientists, clinicians and employees focused on bringing new medicines to patients with debilitating diseases.

Stock Symbol: NKTR

Stock Exchange: NASDAQ

Twitter

 

Company info
Website
Phone
415-482-5300
Location
455 Mission Bay Blvd South
San Francisco
California
94158
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert